// App-Quantinova.ai

: Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Researchers

Presenter

  • Stphanie Fort

Principal Investigators

  • Nafanta Fadiga

  • Olivia Pestrin

  • John Chinawaeze Aneke

  • Shivani Bhat

  • Richard Ward

  • Kevin H. M. Kuo

Medical Centers

  • Department of Medical Oncology and Hematology, University Health Network, Toronto, CAN

  • Faculty of Health Sciences, Queen's University, Kingston, ON, Canada

  • Department of Medicine, University of St Andrews, St Andrews, United Kingdom

  • Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada

  • University Hospital Limerick, Limerick, Ireland

  • Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved